BP-C1 in Metastatic Breast Cancer Patients

NCT01861509 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer
Stage IV Breast Cancer

Interventions

DRUG: BP-C1

Sponsor

Meabco A/S